| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RGNX over the last quarter tilts toward buying: insiders added a net 102,603 shares worth roughly $949K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $3.78M | - | |
| CEO | 338.1K | $2.58M | - | |
| Other | 240.7K | $1.84M | - | |
| Other | 240.3K | $1.83M | - | |
| CFO | 147.1K | $1.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2019 | Kenneth T. Mills81 | President and CEO | Sale+OE | 15,000 | $50.44 | $756,566.18 | -5.7% | |
| Apr 18, 2019 | Patrick J. Christmas | SVP, General Counsel | Sale+OE | 5,000 | $53.23 | $266,161.15 | -62.5% | |
| Apr 15, 2019 | Olivier Danos | Chief Scientific Officer | Sale+OE | 2,000 | $52.66 | $105,320.00 | -23.5% | |
| Mar 21, 2019 | Vittal Vasista79 | Chief Financial Officer | Sell | 10,000 | $60.75 | $607,539.00 | -4.2% | |
| Mar 19, 2019 | Kenneth T. Mills81 | President and CEO | Sale+OE | 15,000 | $58.53 | $877,988.90 | -5.7% | |
| Mar 5, 2019 | Vittal Vasista79 | Chief Financial Officer | Sell | 3,068 | $60.01 | $184,110.68 | -1.3% | |
| Feb 25, 2019 | Curran Simpson64 | SVP, Product Development & CTO | Sale+OE | 5,300 | $54.05 | $286,465.00 | -11.8% | |
| Feb 15, 2019 | Kenneth T. Mills81 | President and CEO | Sale+OE | 15,000 | $47.29 | $709,283.56 | -5.7% | |
| Feb 5, 2019 | Curran Simpson64 | SVP, Product Development & CTO | Sale+OE | 43,832 | $50.08 | $2,195,106.56 | -52.6% | |
| Jan 15, 2019 | Kenneth T. Mills81 | President and CEO | Sell | 15,000 | $43.85 | $657,698.00 | -6.9% |